Story perspectives

WHO Adds GLP-1 Drugs to Essential Medicines List

9/9/2025

29 6

Summary

Story summary

The World Health Organization (WHO) added GLP-1 drugs, like semaglutide and tirzepatide, to its essential medicines list.
These drugs are vital for treating obesity and type 2 diabetes, linked to over 3.7 million deaths in 2021.
WHO calls for affordable generics to enhance access in developing countries facing high costs.
Semaglutide's patent expires next year in several countries, likely boosting generic production.
Analysts foresee market changes, with generics lowering prices and increasing access.

1 of 1

Story summary

The World Health Organization (WHO) added GLP-1 drugs, like semaglutide and tirzepatide, to its essential medicines list.
These drugs are vital for treating obesity and type 2 diabetes, linked to over 3.7 million deaths in 2021.
WHO calls for affordable generics to enhance access in developing countries facing high costs.
Semaglutide's patent expires next year in several countries, likely boosting generic production.
Analysts foresee market changes, with generics lowering prices and increasing access.